Skip to main content

Table 3 Factors associated with HCs for elderly patients with liver cancer in their LML

From: Predictors of high healthcare costs in elderly patients with liver cancer in end-of-life: a longitudinal population-based study

Covariates Estimate O.R. 95% C.I. p value
ICU 2.59 13.34 7.69–23.14 <0.001
Ventilator 1.24 3.46 2.04–5.87 <0.001
Anti-cancer treatmentsa 1.00 2.72 1.60–4.62 <0.001
Admission days 0.22 1.25 1.21–1.30 <0.001
Admission times −0.85 0.43 0.27–0.68 <0.001
CKD 1.07 2.92 1.44–5.93 0.003
EVB 0.81 2.26 1.17–4.36 0.015
Opioids use 0.61 1.85 1.17–2.91 0.009
Ascites −1.08 0.34 0.20–0.59 <0.001
Hypertension −0.52 0.59 0.36–0.99 0.046
Intercept −6.92    <0.001
  1. In this final model, 2049 cases (96.61%) were enrolled for analysis after excluding those (n = 72, 3.39%) with missing data
  2. Abbreviations: ICU intensive care unit, CKD chronic kidney disease, EVB esophageal varices with bleeding
  3. aAnti-cancer treatments included TACE, Radiotherapy, Chemotherapy, HAIC, PEI, and RFA